Structural development studies of PPARs ligands based on tyrosine scaffold

Area of Science:

• Medicinal Chemistry
• Molecular Pharmacology
• Biochemistry

Background:

• Peroxisome proliferator-activated receptors (PPARs) are crucial nuclear receptors regulating lipid and glucose metabolism.
• Developing selective PPAR agonists is key for treating metabolic disorders.

Purpose of the Study:

• To synthesize and evaluate novel stilbene and phenyldiazene analogs as selective PPAR agonists.
• To investigate structural modifications for enhanced PPARγ activity.

Main Methods:

• Synthesis of novel analogs based on tyrosine, incorporating stilbene or phenyldiazene moieties.
• Evaluation of synthesized compounds as PPAR agonists.
• Molecular docking studies to analyze ligand-receptor interactions.

Main Results:

• Novel analogs demonstrated potent and selective PPARγ agonist activity.
• Structural modifications, including phenyloxazole replacement, were effective.
• Molecular docking provided insights into ligand binding mechanisms.

Conclusions:

• The synthesized stilbene and phenyldiazene analogs are potent and selective PPARγ agonists.
• These compounds represent promising candidates for therapeutic development in metabolic diseases.
• Understanding binding interactions can guide future drug design.